Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Akebia Therapeutics Inc. AKBA

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:AKBA)

Fundamentals Snapshot (NDAQ:AKBA)

Opinion & Analysis (NDAQ:AKBA)

No current opinion is available.

Bullboard Posts (NDAQ:AKBA)

PDUFA coming here soon

https://ir.akebia.com/news-releases/news-release-details/akebia-and-otsuka-announce-fda-acceptance-filing-new-drug
Chefboy69 - March 24, 2022

$AKBA AKEBIA SCORES ANOTHER POTENTIAL WIN IN KIDNEY DISEASE!

AKEBIA SCORES ANOTHER POTENTIAL WIN IN KIDNEY DISEASE! https://www.aviseanalytics.com/akebia-scores-another-potential-win-in-kidney...
AviseAnalytics - June 4, 2021

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

it's a buy today for me

this is a turnaround story with the bottom is past,so glta.
coolfooldumbguy - March 12, 2019